We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.92B
AUM Growth
-$967M
Cap. Flow
-$852M
Cap. Flow %
-21.77%
Top 10 Hldgs %
42.44%
Holding
108
New
15
Increased
23
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
MANE
Veradermics Inc
MANE
+$210M
2
CAPR icon
Capricor Therapeutics
CAPR
+$54.2M
3
VMC icon
Vulcan Materials
VMC
+$53.4M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$46.6M
5
PFGC icon
Performance Food Group
PFGC
+$35.4M

Top Sells

Rank Stock Value
1
ERAS icon
Erasca
ERAS
+$131M
2
KO icon
Coca-Cola
KO
+$96.7M
3
MSFT icon
Microsoft
MSFT
+$64.7M
4
NOW icon
ServiceNow
NOW
+$59.7M
5
CRM icon
Salesforce
CRM
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 65.36%
2 Technology 6.7%
3 Consumer Discretionary 5.89%
4 Financials 4.13%
5 Consumer Staples 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARQT icon
1
Arcutis Biotherapeutics
ARQT
$3.56B
$290M 7.42%
12,327,000
+363,000
+3% +$9.26M
MANE
2
Veradermics Inc
MANE
$4.65B
$263M 6.72%
+4,168,970
New +$210M
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$228M 5.81%
350,000
-450,000
-56% -$306M
PVLA
4
Palvella Therapeutics
PVLA
$2.26B
$144M 3.67%
1,153,496
+261,096
+29% +$27.2M
APLS
5
DELISTED
Apellis Pharmaceuticals
APLS
$142M 3.62%
3,518,471
-620,955
-15% -$13.4M
LEGN icon
6
Legend Biotech
LEGN
$4.31B
$137M 3.5%
7,581,029
+972,400
+15% +$18.5M
BNTC icon
7
Benitec Biopharma
BNTC
$439M
$123M 3.14%
11,548,351
– –
CAPR icon
8
Capricor Therapeutics
CAPR
$1.13B
$116M 2.97%
3,818,600
+2,032,990
+114% +$54.2M
IMTX icon
9
Immatics
IMTX
$1.31B
$110M 2.81%
11,190,129
– –
RCUS icon
10
Arcus Biosciences
RCUS
$3.44B
$109M 2.78%
5,030,993
-157,865
-3% -$3.41M
EYPT icon
11
EyePoint Inc
EYPT
$1.12B
$107M 2.73%
8,296,375
+468,690
+6% +$7.01M
AVBP icon
12
ArriVent BioPharma
AVBP
$1.55B
$102M 2.59%
4,401,083
+295,048
+7% +$6.66M
TSM icon
13
TSMC
TSM
$2.07T
$101M 2.58%
298,707
+27,306
+10% +$9.4M
NVDA icon
14
NVIDIA
NVDA
$4.91T
$100M 2.56%
574,656
+43,756
+8% +$8.03M
META icon
15
Meta Platforms (Facebook)
META
$1.64T
$97.1M 2.48%
169,707
+638
+0.4% +$409K
KALV
16
DELISTED
KalVista Pharmaceuticals
KALV
$96M 2.45%
4,768,712
– –
GE icon
17
GE Aerospace
GE
$364B
$88M 2.25%
310,262
– –
BHVN icon
18
Biohaven
BHVN
$2.32B
$87M 2.22%
10,286,937
– –
SYY icon
19
Sysco
SYY
$39.1B
$82.7M 2.11%
1,159,156
+75,366
+7% +$6.23M
MGM icon
20
MGM Resorts International
MGM
$11.8B
$79.9M 2.04%
2,158,800
+956,730
+80% +$34.1M
CMPX icon
21
Compass Therapeutics
CMPX
$369M
$75.7M 1.93%
14,307,379
+125,000
+0.9% +$722K
HD icon
22
Home Depot
HD
$338B
$72.9M 1.86%
221,590
-19,271
-8% -$7.02M
KURA icon
23
Kura Oncology
KURA
$964M
$69.7M 1.78%
8,575,422
– –
GLUE icon
24
Monte Rosa Therapeutics
GLUE
$2.07B
$69.5M 1.78%
4,226,809
+866,809
+26% +$16.6M
BAC icon
25
Bank of America
BAC
$430B
$63.1M 1.61%
1,295,245
-222,385
-15% -$11.5M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Suvretta Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Suvretta Capital Management held 108 positions worth $3.92B, down 20% from $4.88B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management withdrew a net $852M in Q1 2026, closing 19 positions and reducing 16 holdings. Its most notable exit was Coca-Cola, an estimated $96.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 51% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Veradermics Inc worth $263M.

  • Suvretta Capital Management's largest Q1 2026 buy was Veradermics Inc: 4,168,970 shares worth $263M.
  • Suvretta Capital Management added most to Capricor Therapeutics in Q1 2026, an estimated $54.2M increase.
  • Suvretta Capital Management's biggest Q1 2026 reduction was Erasca, cutting an estimated $131M.
  • Suvretta Capital Management fully exited Coca-Cola in Q1 2026, selling an estimated $96.7M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.92B portfolio in Q1 2026.
  • Suvretta Capital Management opened 15 new positions and closed 19 in Q1 2026.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $3.92B.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.